Skip to main content
Fig. 1 | Cell & Bioscience

Fig. 1

From: Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells

Fig. 1

Expression of IL-15 in GBM cells treated with Ad5-Ki67/IL-15. ad ELISA was used to measure IL-15 levels in conditioned media that different glioma cells were treated with Ad5-Ki67/IL-15 (MOI = 40) for 24, 48, 72, and 96 h. Untreated conditioned medium was used as a control. eh IL-15 gene expression in GL261, U251, U87 and primary cells BT-01 treated with Ad5-Ki67/IL-15 for 72 h by qPCR. Untreated GBM cells were used as a control

Back to article page